SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-048270
Filing Date
2013-09-09
Accepted
2013-09-09 17:14:17
Documents
2
Period of Report
2013-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 - ALAFI CAPITAL COMPANY, LLC rrd389908.html 3  
1 FORM 3 - ALAFI CAPITAL COMPANY, LLC rrd389908.xml 3 2076
2 POWER OF ATTORNEY - ALAFI CAPITAL COMPANY, LLC rrd350793_397143.htm EX-24.1 4028
  Complete submission text file 0001181431-13-048270.txt   7576
Mailing Address PO BOX 7338 BERKELEY CA 94707
Business Address
ALAFI CAPITAL CO LLC (Reporting) CIK: 0001216017 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-54896 | Film No.: 131086285

Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations